Aortech International PLC
15 November 2005
For immediate release 15 November 2005
AorTech International plc
('AorTech' or 'the Company')
Directorate Change
AorTech International plc (AIM:AOR), the biomaterials intellectual property and
licensing company, announces the appointment of James Gordon Wright (aged 59)
and Edward McDaid (aged 57) as Non-Executive Directors of the Company with
effect from Monday, 14 November 2005.
The Company is approaching an important phase in the potential commercialisation
of it's bio-materials. The Board welcome the appointment of Gordon and Edward
and believe they will provide appropriate business expertise to assist in the
determination of the Company's future strategy. Gordon Wright and Edward McDaid
are the original founders of the Company.
Gordon Wright represents Caricature Investments Limited which owns 447,107
shares in the Company, being approximately 11.7% of the issued share capital.
Edward McDaid represents Melody Investments Limited and PKF Trustees Limited,
which have a combined interest in 499,383 shares, being approximately 13.1% of
the issued share capital.
For further information please contact:
Buchanan Communications 020 7466 5000
Ben Willey
Rebecca Skye Dietrich
AorTech International plc 0870 850 8286
David Parsons, Company Secretary
The current and previous directorships (over the past five years) of Messers
Wright and McDaid are:
James Gordon Wright AorTech International plc
Sea Breeze Properties Limited
Edward McDaid AorTech International plc
Park Lane Investments (Scotland) Limited
Park Lane Investments (East) Limited
Park Lane Palisade Limited
PLP (Lanarkshire) Limited
PLP (Newlands) Limited
Park Lane Developments Limited
Park Lane Caledonian Group Limited
Park Lane Euromed Limited
Park Lane Rented Homes Limited
Glasgow TV and Film Studio Limited
Park Lane Euromed Limited was wound up in 2004 and the surplus funds distributed
to shareholders.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.